IntraBio News and Activities
Presence
IntraBio develops medicines for rare neurological and metabolic diseases. Its main products are drug candidates, clinical development services, and patient support for hospitals, specialists, and people with unmet treatment needs.
IntraBio products and services overview:
- Rare disease drugs
- Neurology therapies
- Clinical development
- Patient support
Revenue: ~$0 million
Employees: 45
Headquarters: Austin, United States (USA)
IntraBio is one of the...
Executives
View the org chart displaying its 20 main executives
Most searched biographies at IntraBio
- Mallory Factor, Chief Executive Officer and Chairman of the Board
- Christopher Yegen, Director
- Ali Khan, Director
Popular executive movements at IntraBio
- Mark Lubkeman, Chief Operating Officer, has left the company (posted on October 27 2025).
Create your alert
to follow the executive moves at IntraBio.
Biotechnology
IntraBio has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
- RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
- Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
Popular contacts in Biotechnology
News
Press releases by IntraBio
Social media about IntraBio
- IntraBio on Wikipedia, Google News & Yahoo Finance
- IntraBio on LinkedIn, X (Twitter) & YouTube
